Large shareholder group calls for a board overhaul at pharma company CytoDyn


Young chemist working with chemical substances during scientific experiment in laboratory.

skynesher | E+ | Getty Images

Company: CytoDyn Inc. (CYDY)

Business: CytoDyn is a late-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. Its leronlimab is in a class of therapeutic monoclonal antibodies designed to address unmet medical needs in the areas of human immunodeficiency virus (HIV), cancer, immunology, and novel coronavirus disease (Covid-19). It has completed a Phase 3 pivotal trial with leronlimab in combination with antiretroviral therapies…


0 0 votes
Article Rating

Investors bet on Kroger, Costco as Covid-19 cases spook Wall Street

Previous article

Nike could run out of shoes from Vietnam as Covid worsens: S&P Global

Next article

You may also like

Notify of
Inline Feedbacks
View all comments

More in Investing